Registration Opens for the ACCC 48th Annual Meeting and Cancer Center Business Summit

J Clin Pathways. 2022;8(1):19.

Interested in learning about how the convergence of business, policy, and technology leads to solutions for a changing health care industry? Then join the Association of Community of Cancer Centers (ACCC) at its 48th Annual Meeting and Cancer Center Business Summit (AMCCBS), March 2-4, 2022, in Washington DC. Hosted by ACCC, the Cancer Center Business Summit, and Foley & Lardner, LLP. At AMCCBS join health care executives, business leaders, and multidisciplinary providers to explore cutting-edge solutions, get a big picture perspective on the complex and evolving cancer care landscape, and network with key stakeholders who are driving the conversation on the strategies that will advance the delivery of high-quality care. Below is a sneak peek of the dynamic agenda.

On March 2, providers and health care professionals from across the country come together for ACCC’s Hill Day. After meeting with Congressional representatives, AMCCBS kicks off with a session on “What’s New with Big Data.” At this panel session, learn how cancer programs and practices are using their data; the latest strategies for data security and how to guard against and respond to data breaches; and how to monetize patient data, including who’s selling and who’s buying, as well as the ethics of selling patient data.

March 3 opens with a keynote on “(Over)-Paying for Cancer Care” by Cary Gross, MD, professor of medicine and director of the Cancer Outcomes Public Policy and Effectiveness Research (COPPER) Center at Yale School of Medicine and coauthor of A New Deal for Cancer Care: Lessons From a 50 Year War. During the morning break, join Dr. Gross and several of his coauthors for a special book signing. 

Next during “Industry Reconfiguration: Who’s the Boss?” an expert panel provides an overview of industry reconfiguration and consolidation trends and its impact on oncology. Then attendees will hear the value propositions of three different business models and how each improves cancer care services in access, quality, outcomes, and cost, followed by a lively discussion of how these models may impact the delivery of cancer care going forward, including an interactive audience Q&A.

For the remainder of the day, attendees can choose between two tracks offering a wide range of topics like:

• Mount Sinai Health System’s “Benefits of an Early Mobility Program for Hospitalized Patients with Cancer”
• The University of Texas Dell Medical School, LIVESTRONG Cancer Institute session on “How to Evaluate the Impact of Cancer Programs and Clinical Services
• A Johns Hopkins Hospital-led discussion entitled “Re-Thinking Survivorship Care.”

The last day of the meeting, Friday, March 4, starts off with a keynote from Harlan Levine, MD, president, Strategy and Business Ventures, City of Hope National Medical Center, on “Deconstructing the Value Equation.” Hear what value in cancer care means to patients and their caregivers and how this meaning is usually different for payers and employers. Then consider how we define value in oncology reflects on us as a society. Strategize how these different perspectives fit together to yield a value equation that considers outcomes, patient experience, cost, and time. A half-day of general sessions follow on topics like “Making the Business Case for Providing Comprehensive Cancer Care Services,” “Precision Medicine vs Value-Based Payment,” and “What’s Trending in Pharmacy and Infusion Services.” 

Take a look at the full agenda online.